St. Jude Medical (STJ) 83.51 $STJ
Booming Medical Tourism Industry in Emerging Economies to Propel Global Cardiovascular Monitoring and Diagnostic Devices Market, Reports TMR
PR Newswire - Wed Aug 03, 5:30AM CDT
Intense competition and high entry barriers outline the present state of the competitive landscape of the global cardiovascular monitoring and diagnostic devices market, states a recent Transparency Market Research (TMR) report. In the markedly consolidated market, the top two vendors, GE Healthcare and Philips Healthcare, accounted for a more than 55% share in 2015. Moreover, these two companies have their headquarters in Europe, granting this regional market a high level of saturation. The other half of the competitive landscape is, however, highly fragmented with a large number of specialty vendors operating in regional pockets.
STJ: 83.51 (-0.01)
Uptrend Call Working As St Jude Medical Stock Rises 54.2% (STJ)
Comtex SmarTrend(R) - Wed Aug 03, 12:16AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 5 months, St Jude Medical has returned 54.15% as of today's recent price of $83.52.
STJ: 83.51 (-0.01)
St. Jude Medical (STJ) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:43PM CDT
St. Jude Medical Inc. (STJ) is set to report second-quarter 2016 earning results on Jul 20.
INVA: 12.87 (+0.03), CYTR: 0.57 (unch), STJ: 83.51 (-0.01), WCG: 112.00 (+0.09)
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 8:30AM CDT
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
ABT: 45.04 (-0.03), SNN: 33.26 (-0.22), JNJ: 124.32 (-0.53), MDT: 87.50 (-0.14), STJ: 83.51 (-0.01)
MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 119.50 (+0.59), LDRH: 36.98 (-0.02), MDT: 87.50 (-0.14), PAHC: 21.03 (+0.06), MLAB: 108.01 (-0.26), NUVA: 62.38 (-0.25), BSX: 24.17 (unch), BABY: 38.26 (-0.19), SNN: 33.26 (-0.22), JNJ: 124.32 (-0.53), DXCM: 92.45 (-0.33), GWPH: 94.34 (+0.27), RMD: 69.27 (-0.11), WOOF: 69.75 (+0.05), ABT: 45.04 (-0.03), VIVO: 19.26 (-0.03), MASI: 52.74 (+0.20), TMO: 156.48 (+0.04), CYH: 11.60 (-0.60), HTWR: 57.92 (+0.03), FEIC: 106.83 (+0.18), ISRG: 691.71 (+1.22), CFMS: 6.76 (-0.07), STE: 70.52 (-0.24), STJ: 83.51 (-0.01), XRAY: 64.58 (-0.05), HOLX: 39.10 (+0.07)
Hill-Rom: Welch-Allyn Synergy Continues, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 7:50AM CDT
On Jul 11, we issued an updated research report on medical device manufacturer Hill-Rom Holdings, Inc. (HRC).
BSX: 24.17 (unch), ENZY: 9.07 (unch), STJ: 83.51 (-0.01), HRC: 53.75 (-0.09)
Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020 with Kinetics Drive Solutions & Bosch Rexroth St. Jude Medical Dominating
GlobeNewswire - Tue Jul 12, 5:28AM CDT
Research and Markets has announced the addition of the "Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020" report to their offering.
STJ: 83.51 (-0.01)
St Jude Medical Has Returned 49.2% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Mon Jul 11, 12:51PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 5 months, St Jude Medical has returned 49.24% as of today's recent price of $80.86.
STJ: 83.51 (-0.01)
St. Jude Medical Continues to Expand its Heart Failure Portfolio in the U.S. to Provide Physicians Additional Options for Managing Patients Not Responding to Other Therapies
BusinessWire - Mon Jul 11, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Food and Drug Administration (FDA) approval and the launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. The SyncAV CRT software algorithm is designed to function independently or in conjunction with MultiPoint Pacing Technology to address and effectively treat heart failure patients, some of whom are not responsive to other pacing options.
STJ: 83.51 (-0.01)
Research and Markets - Global LVAD Market 2016-2020 with Abiomed, Berlin Heart, HeartWare International, Jarvik Heart & St. Jude Medical Dominating
PR Newswire Europe - Thu Jul 07, 12:10PM CDT
Research and Markets has announced the addition of the "Global LVAD Market 2016-2020" [http://www.researchandmarkets.com/research/s6lm9k/global_lvad] report to their offering.
STJ: 83.51 (-0.01)
Abbott Labs' Absorb Stent Gets Regulatory Approval in U.S.
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Abbott Laboratories (ABT) received a major boost when the FDA approved its bioresorbable heart stent, Absorb, for the treatment of coronary artery disease in the U.S.
ABT: 45.04 (-0.03), JNJ: 124.32 (-0.53), PFE: 35.57 (-0.82), STJ: 83.51 (-0.01)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 45.04 (-0.03), JNJ: 124.32 (-0.53), ZBH: 130.53 (-0.06), LDRH: 36.98 (-0.02), MDT: 87.49 (-0.15), TMO: 156.48 (+0.04), STJ: 83.51 (-0.01), HTWR: 57.92 (+0.03), XRAY: 64.58 (-0.05), NUVA: 62.38 (-0.25), FEIC: 106.83 (+0.18)
What Investors are Making of These Medical Appliances and Equipment Stocks? - St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Thu Jul 07, 6:40AM CDT
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
VAR: 94.41 (-0.05), STE: 70.52 (-0.24), RMD: 69.27 (-0.11), STJ: 83.51 (-0.01), MDSY: 1.47 (unch)
St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies
BusinessWire - Thu Jun 23, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced CE Mark approval and launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. MultiPoint Pacing technology with the SyncAV CRT software algorithm is designed to address and effectively treat heart failure patients who are not responsive to other pacing options. The SyncAV technology, which automatically adjusts pacing based on real-time changes in a patient's cardiac condition, also provides physicians the opportunity to further improve treatment of patients who have responded positively to traditional CRT.
STJ: 83.51 (-0.01)
Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 79.05 (+0.10), LMAT: 17.54 (+0.15), STJ: 83.51 (-0.01), NUVA: 62.38 (-0.25)
Uptrend Call Working As St Jude Medical Stock Rises 40.8% (STJ)
Comtex SmarTrend(R) - Thu Jun 16, 12:51PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 40.85% as of today's recent price of $76.31.
STJ: 83.51 (-0.01)
Lieberman Software Hosts Privilege Management Security Panel at Gartner Security & Risk Management Summit
Marketwired - Tue Jun 14, 4:30AM CDT
LOS ANGELES, CA--(Marketwired - Jun 14, 2016) - Lieberman Software Corporation today announced that it's leading a cyber security panel today at Gartner Security & Risk Management Summit 2016. Protecting Privilege as Cyber Defense - A Panel Discussion will be hosted by Jonathan Sander, Vice President of Product Strategy at Lieberman Software.
STJ: 83.51 (-0.01)
India Cardiovascular Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, St. Jude Medical, Abbott Labs - Research and Markets
BusinessWire - Fri Jun 10, 12:10PM CDT
Research and Markets has announced the addition of the "India Cardiovascular Devices Market Outlook to 2021 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others" report to their offering.
ABT: 45.04 (-0.03), MDT: 87.49 (-0.15), STJ: 83.51 (-0.01)
43.9% Return Seen to Date on SmarTrend St Jude Medical Call (STJ)
Comtex SmarTrend(R) - Thu Jun 09, 12:23AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 43.89% as of today's recent price of $77.96.
STJ: 83.51 (-0.01)
Booming Medical Tourism Industry in Emerging Economies to Propel Global Cardiovascular Monitoring and Diagnostic Devices Market, Reports TMR
PR Newswire - Wed Aug 03, 5:30AM CDT
Intense competition and high entry barriers outline the present state of the competitive landscape of the global cardiovascular monitoring and diagnostic devices market, states a recent Transparency Market Research (TMR) report. In the markedly consolidated market, the top two vendors, GE Healthcare and Philips Healthcare, accounted for a more than 55% share in 2015. Moreover, these two companies have their headquarters in Europe, granting this regional market a high level of saturation. The other half of the competitive landscape is, however, highly fragmented with a large number of specialty vendors operating in regional pockets.
STJ: 83.51 (-0.01)
Uptrend Call Working As St Jude Medical Stock Rises 54.2% (STJ)
Comtex SmarTrend(R) - Wed Aug 03, 12:16AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 5 months, St Jude Medical has returned 54.15% as of today's recent price of $83.52.
STJ: 83.51 (-0.01)
St. Jude Medical (STJ) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:43PM CDT
St. Jude Medical Inc. (STJ) is set to report second-quarter 2016 earning results on Jul 20.
INVA: 12.87 (+0.03), CYTR: 0.57 (unch), STJ: 83.51 (-0.01), WCG: 112.00 (+0.09)
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 8:30AM CDT
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
ABT: 45.04 (-0.03), SNN: 33.26 (-0.22), JNJ: 124.32 (-0.53), MDT: 87.50 (-0.14), STJ: 83.51 (-0.01)
MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 119.50 (+0.59), LDRH: 36.98 (-0.02), MDT: 87.50 (-0.14), PAHC: 21.03 (+0.06), MLAB: 108.01 (-0.26), NUVA: 62.38 (-0.25), BSX: 24.17 (unch), BABY: 38.26 (-0.19), SNN: 33.26 (-0.22), JNJ: 124.32 (-0.53), DXCM: 92.45 (-0.33), GWPH: 94.34 (+0.27), RMD: 69.27 (-0.11), WOOF: 69.75 (+0.05), ABT: 45.04 (-0.03), VIVO: 19.26 (-0.03), MASI: 52.74 (+0.20), TMO: 156.48 (+0.04), CYH: 11.60 (-0.60), HTWR: 57.92 (+0.03), FEIC: 106.83 (+0.18), ISRG: 691.71 (+1.22), CFMS: 6.76 (-0.07), STE: 70.52 (-0.24), STJ: 83.51 (-0.01), XRAY: 64.58 (-0.05), HOLX: 39.10 (+0.07)
Hill-Rom: Welch-Allyn Synergy Continues, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 7:50AM CDT
On Jul 11, we issued an updated research report on medical device manufacturer Hill-Rom Holdings, Inc. (HRC).
BSX: 24.17 (unch), ENZY: 9.07 (unch), STJ: 83.51 (-0.01), HRC: 53.75 (-0.09)
Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020 with Kinetics Drive Solutions & Bosch Rexroth St. Jude Medical Dominating
GlobeNewswire - Tue Jul 12, 5:28AM CDT
Research and Markets has announced the addition of the "Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020" report to their offering.
STJ: 83.51 (-0.01)
St Jude Medical Has Returned 49.2% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Mon Jul 11, 12:51PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 5 months, St Jude Medical has returned 49.24% as of today's recent price of $80.86.
STJ: 83.51 (-0.01)
St. Jude Medical Continues to Expand its Heart Failure Portfolio in the U.S. to Provide Physicians Additional Options for Managing Patients Not Responding to Other Therapies
BusinessWire - Mon Jul 11, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Food and Drug Administration (FDA) approval and the launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. The SyncAV CRT software algorithm is designed to function independently or in conjunction with MultiPoint Pacing Technology to address and effectively treat heart failure patients, some of whom are not responsive to other pacing options.
STJ: 83.51 (-0.01)
Research and Markets - Global LVAD Market 2016-2020 with Abiomed, Berlin Heart, HeartWare International, Jarvik Heart & St. Jude Medical Dominating
PR Newswire Europe - Thu Jul 07, 12:10PM CDT
Research and Markets has announced the addition of the "Global LVAD Market 2016-2020" [http://www.researchandmarkets.com/research/s6lm9k/global_lvad] report to their offering.
STJ: 83.51 (-0.01)
Abbott Labs' Absorb Stent Gets Regulatory Approval in U.S.
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Abbott Laboratories (ABT) received a major boost when the FDA approved its bioresorbable heart stent, Absorb, for the treatment of coronary artery disease in the U.S.
ABT: 45.04 (-0.03), JNJ: 124.32 (-0.53), PFE: 35.57 (-0.82), STJ: 83.51 (-0.01)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 45.04 (-0.03), JNJ: 124.32 (-0.53), ZBH: 130.53 (-0.06), LDRH: 36.98 (-0.02), MDT: 87.49 (-0.15), TMO: 156.48 (+0.04), STJ: 83.51 (-0.01), HTWR: 57.92 (+0.03), XRAY: 64.58 (-0.05), NUVA: 62.38 (-0.25), FEIC: 106.83 (+0.18)
What Investors are Making of These Medical Appliances and Equipment Stocks? - St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Thu Jul 07, 6:40AM CDT
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
VAR: 94.41 (-0.05), STE: 70.52 (-0.24), RMD: 69.27 (-0.11), STJ: 83.51 (-0.01), MDSY: 1.47 (unch)
St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies
BusinessWire - Thu Jun 23, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced CE Mark approval and launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. MultiPoint Pacing technology with the SyncAV CRT software algorithm is designed to address and effectively treat heart failure patients who are not responsive to other pacing options. The SyncAV technology, which automatically adjusts pacing based on real-time changes in a patient's cardiac condition, also provides physicians the opportunity to further improve treatment of patients who have responded positively to traditional CRT.
STJ: 83.51 (-0.01)
Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 79.05 (+0.10), LMAT: 17.54 (+0.15), STJ: 83.51 (-0.01), NUVA: 62.38 (-0.25)
Uptrend Call Working As St Jude Medical Stock Rises 40.8% (STJ)
Comtex SmarTrend(R) - Thu Jun 16, 12:51PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 40.85% as of today's recent price of $76.31.
STJ: 83.51 (-0.01)
Lieberman Software Hosts Privilege Management Security Panel at Gartner Security & Risk Management Summit
Marketwired - Tue Jun 14, 4:30AM CDT
LOS ANGELES, CA--(Marketwired - Jun 14, 2016) - Lieberman Software Corporation today announced that it's leading a cyber security panel today at Gartner Security & Risk Management Summit 2016. Protecting Privilege as Cyber Defense - A Panel Discussion will be hosted by Jonathan Sander, Vice President of Product Strategy at Lieberman Software.
STJ: 83.51 (-0.01)
India Cardiovascular Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, St. Jude Medical, Abbott Labs - Research and Markets
BusinessWire - Fri Jun 10, 12:10PM CDT
Research and Markets has announced the addition of the "India Cardiovascular Devices Market Outlook to 2021 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others" report to their offering.
ABT: 45.04 (-0.03), MDT: 87.49 (-0.15), STJ: 83.51 (-0.01)
43.9% Return Seen to Date on SmarTrend St Jude Medical Call (STJ)
Comtex SmarTrend(R) - Thu Jun 09, 12:23AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 43.89% as of today's recent price of $77.96.
STJ: 83.51 (-0.01)
